Drug intelligence / Profile preview

ferumoxides (AMAG Pharmaceuticals, Inc.)

Development stage
Discontinued
Lead developer
Azurity Pharmaceuticals
Modality
Nanoparticles → Drug Delivery Systems
Administration
Intravenous
01

Overview

Ferumoxides is a superparamagnetic iron oxide (SPIO) contrast agent composed of non-stoichiometric magnetite (Fe3O4) and maghemite (gamma-Fe2O3) nanoparticles coated with dextran. It is primarily used in magnetic resonance imaging (MRI) for the detection and characterization of focal liver and splenic lesions. Following intravenous administration, the particles are rapidly cleared from the blood by the reticuloendothelial system (RES), specifically Kupffer cells in the liver and macrophages in the spleen. This selective uptake causes a significant reduction in T2 and T2* signal intensity in normal parenchyma due to the intense relaxativity of the iron oxide core. Lesions that lack functional RES cells, such as hepatocellular carcinoma or metastases, do not take up the agent and appear relatively hyperintense against the darkened healthy tissue, thereby enhancing lesion-to-background contrast and improving detection rates.

Brand names
FeridexEndorem
Other names
dextran-coated magnetiteDMsuperparamagnetic iron oxideSPIOferumoxide

Beyond the preview

Go deeper on ferumoxides (AMAG Pharmaceuticals, Inc.).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ferumoxides (AMAG Pharmaceuticals, Inc.).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call